Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Follow-Up Questions
What is Cosmos Health Inc (COSM)'s P/E Ratio?
The P/E ratio of Cosmos Health Inc is N/A
Who is the CEO of Cosmos Health Inc?
Mr. Grigorios Siokas is the Chairman of the Board of Cosmos Health Inc, joining the firm since 2016.
What is the price performance of COSM stock?
The current price of COSM is 0.945, it has increased 1.4% in the last trading day.
What are the primary business themes or industries for Cosmos Health Inc?
Cosmos Health Inc belongs to Health Care industry and the sector is Health Care
What is Cosmos Health Inc market cap?
Cosmos Health Inc's current market cap is $28.5
Is Cosmos Health Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Cosmos Health Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
